Market Price

11.70 

0.48 4.3%

as of Sep 30 '22

52 Week Range:

10.76 18.57


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Equity (BVPS) 3.42
4.30
4.38
4.49
4.52
4.50
4.80
5.23
5.59
5.66
6.06
growth rate 25.7% 1.9% 2.5% 0.7% -0.4% 6.7% 9.0% 6.9% 1.3% 7.1%
Earnings BIT 888.00
932.00
745.00
912.00
885.00
976.00
981.00
433.00
712.00
growth rate 5.0% -20.1% 22.4% -3.0% 10.3% 0.5% -55.9% 64.4%
Avg.PE 36.54
16.92
19.78
21.84
21.84
21.84
21.84
growth rate -53.7% 16.9% 10.4% 0.0% 0.0% 0.0%
ROA 12.28
14.03
9.70
7.63
5.67
10.81
10.09
8.33
6.91
4.41
4.78
growth rate 14.3% -30.9% -21.3% -25.7% 90.7% -6.7% -17.4% -17.1% -36.2% 8.4%
ROE 19.53
20.62
14.02
12.39
10.24
19.79
17.83
13.93
11.98
8.60
9.66
growth rate 5.6% -32.0% -11.6% -17.4% 93.3% -9.9% -21.9% -14.0% -28.2% 12.3%
ROIC 16.83
19.58
12.76
10.28
8.01
15.01
14.02
11.53
9.65
6.24
6.73
growth rate 16.3% -34.8% -19.4% -22.1% 87.4% -6.6% -17.8% -16.3% -35.3% 7.9%
Cur. Ratio 1.86
2.31
2.10
2.10
1.84
1.88
2.02
2.10
2.06
2.76
2.08
growth rate 24.2% -9.1% 0.0% -12.4% 2.2% 7.5% 4.0% -1.9% 34.0% -24.6%
Quick Ratio 1.09
1.32
1.14
1.04
0.91
0.92
1.04
1.12
1.00
1.64
1.11
growth rate 21.1% -13.6% -8.8% -12.5% 1.1% 13.0% 7.7% -10.7% 64.0% -32.3%
Leverage 1.49
1.45
1.44
1.81
1.81
1.86
1.69
1.65
1.81
2.08
1.96
growth rate -2.7% -0.7% 25.7% 0.0% 2.8% -9.1% -2.4% 9.7% 14.9% -5.8%
Balance Sheet Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Acct.Receivable 980.00
995.00
1,019.00
1,022.00
1,064.00
1,148.00
1,211.00
1,227.00
1,106.00
1,172.00
growth rate 1.5% 2.4% 0.3% 4.1% 7.9% 5.5% 1.3% -9.9% 6.0%
Acct.Payable 646.00
751.00
807.00
808.00
807.00
873.00
854.00
941.00
891.00
1,043.00
growth rate 16.3% 7.5% 0.1% -0.1% 8.2% -2.2% 10.2% -5.3% 17.1%
Cur.Assets 2,144.00
2,256.00
2,440.00
2,475.00
2,529.00
2,731.00
3,077.00
3,219.00
4,664.00
4,424.00
growth rate 5.2% 8.2% 1.4% 2.2% 8.0% 12.7% 4.6% 44.9% -5.2%
Total Assets 5,642.00
5,819.00
7,306.00
7,167.00
7,344.00
7,866.00
8,059.00
9,299.00
11,012.00
10,920.00
growth rate 3.1% 25.6% -1.9% 2.5% 7.1% 2.5% 15.4% 18.4% -0.8%
Cash 178.00
137.00
93.00
120.00
100.00
169.00
365.00
277.00
1,762.00
1,290.00
growth rate -23.0% -32.1% 29.0% -16.7% 69.0% 116.0% -24.1% 536.1% -26.8%
Inventory 901.00
1,006.00
1,181.00
1,217.00
1,244.00
1,304.00
1,395.00
1,614.00
1,691.00
1,844.00
growth rate 11.7% 17.4% 3.1% 2.2% 4.8% 7.0% 15.7% 4.8% 9.1%
Cur.Liabilities 930.00
1,073.00
1,162.00
1,344.00
1,348.00
1,346.00
1,465.00
1,564.00
1,688.00
2,131.00
growth rate 15.4% 8.3% 15.7% 0.3% -0.2% 8.8% 6.8% 7.9% 26.2%
Liabilities 1,758.00
1,772.00
3,266.00
3,201.00
3,386.00
3,222.00
3,185.00
4,158.00
5,733.00
5,352.00
growth rate 0.8% 84.3% -2.0% 5.8% -4.8% -1.2% 30.6% 37.9% -6.7%
LT Debt 416.00
335.00
1,656.00
1,426.00
1,559.00
1,423.00
1,301.00
1,851.00
3,207.00
2,707.00
growth rate -19.5% 394.3% -13.9% 9.3% -8.7% -8.6% 42.3% 73.3% -15.6%
Equity 4,047.00
4,040.00
3,966.00
3,958.00
4,644.00
4,874.00
5,141.00
5,279.00
5,568.00
growth rate -0.2% -1.8% -0.2% 17.3% 5.0% 5.5% 2.7% 5.5%
Common Shares 895.00
901.00
906.00
899.00
899.00
893.00
875.00
177.00
177.00
177.00
177.00
growth rate 0.7% 0.6% -0.8% 0.0% -0.7% -2.0% -79.8% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Capital Expenditures 265.00
340.00
298.00
303.00
320.00
376.00
347.00
408.00
443.00
408.00
growth rate 28.3% -12.4% 1.7% 5.6% 17.5% -7.7% 17.6% 8.6% -7.9%
Cash Dividends 239.00
250.00
272.00
279.00
269.00
321.00
318.00
328.00
329.00
growth rate 4.6% 8.8% 2.6% -3.6% 19.3% -0.9% 3.1% 0.3%
Cash From OA 902.00
867.00
683.00
1,030.00
849.00
1,090.00
931.00
1,168.00
935.00
877.00
growth rate -3.9% -21.2% 50.8% -17.6% 28.4% -14.6% 25.5% -20.0% -6.2%
FCF per Share 0.63
0.70
0.56
0.36
0.63
0.49
0.60
0.75
0.87
0.40
0.91
growth rate 11.1% -20.0% -35.7% 75.0% -22.2% 22.5% 25.0% 16.0% -54.0% 127.5%
Sale Purchase of Stock 51.00
44.00
21.00
16.00
10.00
growth rate -13.7% -52.3% -23.8% -37.5%
FCF 521.00
637.00
527.00
308.00
672.00
457.00
714.00
584.00
760.00
492.00
469.00
growth rate 22.3% -17.3% -41.6% 118.2% -32.0% 56.2% -18.2% 30.1% -35.3% -4.7%
Income Statement Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21
Sales 4,137.00
4,351.00
4,617.00
4,634.00
4,669.00
4,765.00
4,904.00
5,138.00
4,560.00
5,212.00
growth rate 5.2% 6.1% 0.4% 0.8% 2.1% 2.9% 4.8% -11.3% 14.3%
Op.Income 721.00
888.00
932.00
745.00
912.00
885.00
976.00
981.00
433.00
712.00
growth rate 23.2% 5.0% -20.1% 22.4% -3.0% 10.3% 0.5% -55.9% 64.4%
IBT 802.00
714.00
559.00
1,062.00
879.00
781.00
743.00
246.00
586.00
growth rate -11.0% -21.7% 90.0% -17.2% -11.2% -4.9% -66.9% 138.2%
Net Income 721.00
556.00
501.00
410.00
784.00
767.00
663.00
600.00
448.00
524.00
growth rate -22.9% -9.9% -18.2% 91.2% -2.2% -13.6% -9.5% -25.3% 17.0%
EPS 0.64
0.80
0.61
0.56
0.46
0.88
0.88
0.76
0.68
0.51
0.59
growth rate 25.0% -23.8% -8.2% -17.9% 91.3% 0.0% -13.6% -10.5% -25.0% 15.7%
Gross Profit 3,070.00
3,268.00
3,490.00
3,491.00
3,397.00
3,517.00
3,606.00
3,807.00
3,179.00
3,698.00
growth rate 6.5% 6.8% 0.0% -2.7% 3.5% 2.5% 5.6% -16.5% 16.3%
R&D 231.00
235.00
222.00
230.00
223.00
246.00
292.00
307.00
349.00
growth rate 1.7% -5.5% 3.6% -3.0% 10.3% 18.7% 5.1% 13.7%

Quarterly Statements

Item Name Apr '21 Jul '21 Dec '21 Apr '22 Jul '22
Earnings BIT 119.50
236.50
236.50
121.00
121.00
growth rate 97.9% 0.0% -48.8% 0.0%
Balance Sheet Apr '21 Jul '21 Dec '21 Apr '22 Jul '22
Acct.Receivable 1,305.00
1,172.00
1,172.00
1,253.00
1,253.00
growth rate -10.2% 0.0% 6.9% 0.0%
Acct.Payable 1,046.00
1,043.00
1,043.00
1,013.00
1,013.00
growth rate -0.3% 0.0% -2.9% 0.0%
Cur.Assets 4,442.00
4,424.00
4,424.00
3,759.00
3,759.00
growth rate -0.4% 0.0% -15.0% 0.0%
Total Assets 10,933.00
10,920.00
10,920.00
10,105.00
10,105.00
growth rate -0.1% 0.0% -7.5% 0.0%
Cash 1,387.00
1,290.00
1,290.00
516.00
516.00
growth rate -7.0% 0.0% -60.0% 0.0%
Inventory 1,750.00
1,844.00
1,844.00
1,990.00
1,990.00
growth rate 5.4% 0.0% 7.9% 0.0%
Cur.Liabilities 2,120.00
2,131.00
2,131.00
2,117.00
2,117.00
growth rate 0.5% 0.0% -0.7% 0.0%
Liabilities 5,602.00
5,352.00
5,352.00
4,710.00
4,710.00
growth rate -4.5% 0.0% -12.0% 0.0%
LT Debt 2,781.00
2,707.00
2,707.00
2,154.00
2,154.00
growth rate -2.7% 0.0% -20.4% 0.0%
Equity 5,331.00
5,568.00
5,568.00
5,395.00
5,395.00
growth rate 4.5% 0.0% -3.1% 0.0%
Common Shares 177.00
177.00
177.00
175.00
175.00
growth rate 0.0% 0.0% -1.1% 0.0%
Cash Flow Statement Apr '21 Jul '21 Dec '21 Apr '22 Jul '22
Capital Expenditures 87.50
116.50
116.50
86.50
86.50
growth rate 33.1% 0.0% -25.8% 0.0%
Cash Dividends 101.50
63.00
63.00
101.00
101.00
growth rate -37.9% 0.0% 60.3% 0.0%
Cash From OA 181.50
257.00
257.00
103.50
103.50
growth rate 41.6% 0.0% -59.7% 0.0%
Sale Purchase of Stock
growth rate
FCF 94.00
140.50
140.50
17.00
17.00
growth rate 49.5% 0.0% -87.9% 0.0%
Income Statement Apr '21 Jul '21 Dec '21 Apr '22 Jul '22
Sales 1,299.50
1,306.50
1,306.50
1,300.00
1,300.00
growth rate 0.5% 0.0% -0.5% 0.0%
Op.Income 119.50
236.50
236.50
121.00
121.00
growth rate 97.9% 0.0% -48.8% 0.0%
IBT 111.50
181.50
181.50
102.00
102.00
growth rate 62.8% 0.0% -43.8% 0.0%
Net Income 102.50
159.50
159.50
88.50
88.50
growth rate 55.6% 0.0% -44.5% 0.0%
Gross Profit 896.50
952.50
952.50
913.50
913.50
growth rate 6.3% 0.0% -4.1% 0.0%
R&D 85.50
89.00
89.00
87.00
87.00
growth rate 4.1% 0.0% -2.3% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

F (13.61)

YOY Growth Grade:

F (15.42)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 22.85 22.85 11.25
EPS / Growth 5.2% 0.51 9.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 5.1%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 5.1% 6.4% 6.4%
Future PE 10.10 15.64 15.64
Future EPS 0.84 0.95 0.95
Value Price
MOS %
2.09
-82.1%
3.68
-68.5%
3.68
-68.5%
MOS Price 1.05 1.84 1.84
IRT 15.04 13.93 13.93

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.